Lupin Ltd.

₹2,129.5

-21 (-1%)

LUPIN Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 97,371 Cr

P/E Ratio29.63

Dividend Yield0.28 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	2,144.22	Bearish
10-DMA	2,161.93	Bearish
20-DMA	2,151.33	Bearish
50-DMA	2,107.41	Bullish
100-DMA	2,039.42	Bullish
200-DMA	2,005.2	Bullish

Historical Performance

1 Year

5.3%

3 Years

187%

5 Years

102.9%

10 Years

24.8%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	2,27,079	2,00,108	1,66,417	1,64,055	1,51,630
Total Expenditure	1,74,304	1,62,217	1,49,211	1,61,902	1,25,961
Other Income	2,016	1,416	1,509	2,137	1,363
Operating Profit	54,791	39,307	18,715	4,289	27,032
Interest	2,949	3,116	2,743	1,428	1,406
Depreciation	11,693	11,968	8,807	16,587	8,874
Profit Before Tax	40,150	24,223	7,165	-13,722	16,764
Consolidated Net Profit	32,816	19,145	4,301	-15,280	12,165
Adjusted EPS	72	42	9	-34	27

Compounded Sales Growth

10 Years:12.2

5 Years:8.1

3 Years:6.7

TTM:2.6

Compounded Profit Growth

10 Years:6.4

5 Years:33.4

3 Years:-5.7

TTM:11.4

Stock Price CAGR

10 Years:2.2

5 Years:16.1

3 Years:42.1

TTM:3

Return on Equity

10 Years:50.2

5 Years:26.8

3 Years:9.5

last year:71.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	913	911	910	909	907
Total Reserves	1,70,282	1,40,847	1,22,246	1,19,006	1,35,229
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	23,900	8,197	9,921	11,531	11,360
Other Current Liabilities	22,743	19,194	15,772	13,941	27,667
Short Term Borrowings	30,156	26,699	42,165	37,023	30,494
Total Liabilities	2,86,458	2,36,946	2,28,003	2,16,515	2,34,302
Capital Work in Progress	3,554	5,957	8,948	8,475	8,515
Long Term Loans & Advances	3,078	3,206	6,209	5,724	4,058
Currents Investments	10,591	8,469	4,398	8,224	23,768
Short Term Loans and Advances	3,126	3,242	2,260	11,469	7,439
Total Current Assets	1,67,986	1,34,476	1,24,513	1,24,577	1,39,864
Total Assets	2,86,458	2,36,946	2,28,003	2,16,515	2,34,302
Adjusted Book Value	375	311	271	264	300

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 29.63, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 42.6%, indicating sustained price appreciation.
The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹54791 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹227079 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1029664.2

No. of Shares: 484 (Approx)

Performance:3%

P/L: ₹29664.2

NIFTY Performance: 9.4%

1 day Top Gainers